A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma

Clinical trial NCT05900765 · UNKNOWN

Trial details

NCT number: NCT05900765
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Classical Hodgkin Lymphoma

Start date: 2023-06-14
Primary completion: 2025-06-30
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.